These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 25885794

  • 21. Ligand-free estrogen receptor activity complements IGF1R to induce the proliferation of the MCF-7 breast cancer cells.
    Gaben AM, Sabbah M, Redeuilh G, Bedin M, Mester J.
    BMC Cancer; 2012 Jul 16; 12():291. PubMed ID: 22799881
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma.
    Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S, Onetti Muda A, Dostal DE, De Santis A, Attili AF, Benedetti A, Gaudio E.
    Am J Pathol; 2006 Sep 16; 169(3):877-88. PubMed ID: 16936263
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.
    Sirianni R, Zolea F, Chimento A, Ruggiero C, Cerquetti L, Fallo F, Pilon C, Arnaldi G, Carpinelli G, Stigliano A, Pezzi V.
    J Clin Endocrinol Metab; 2012 Dec 16; 97(12):E2238-50. PubMed ID: 23074235
    [Abstract] [Full Text] [Related]

  • 28. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP.
    Cancer; 2006 Jun 15; 106(12):2610-6. PubMed ID: 16700038
    [Abstract] [Full Text] [Related]

  • 29. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.
    Armand AS, Lécolle S, Launay T, Pariset C, Fiore F, Della Gaspera B, Birnbaum D, Chanoine C, Charbonnier F.
    Exp Cell Res; 2004 Jul 01; 297(1):27-38. PubMed ID: 15194422
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of insulin-like growth factor I activity contributes to the premature apoptosis of cerebellar granule neuron in weaver mutant mice: in vitro analysis.
    Zhong J, Deng J, Ghetti B, Lee WH.
    J Neurosci Res; 2002 Oct 01; 70(1):36-45. PubMed ID: 12237862
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enhancement of AG1024-induced H9c2 cardiomyoblast cell apoptosis via the interaction of IGF2R with Galpha proteins and its downstream PKA and PLC-beta modulators by IGF-II.
    Chu CH, Huang CY, Lu MC, Lin JA, Tsai FJ, Tsai CH, Chu CY, Kuo WH, Chen LM, Chen LY.
    Chin J Physiol; 2009 Feb 28; 52(1):31-7. PubMed ID: 19764351
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.
    Wetmore C, Eberhart DE, Curran T.
    Cancer Res; 2001 Jan 15; 61(2):513-6. PubMed ID: 11212243
    [Abstract] [Full Text] [Related]

  • 36. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 37. MiR-15b is a key regulator of proliferation and apoptosis of chondrocytes from patients with condylar hyperplasia by targeting IGF1, IGF1R and BCL2.
    Cao P, Feng Y, Deng M, Li J, Cai H, Meng Q, Fang W, Li Y, Ke J, Long X.
    Osteoarthritis Cartilage; 2019 Feb 01; 27(2):336-346. PubMed ID: 30521861
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW, Pollak M, Huynh H.
    Clin Cancer Res; 2001 Aug 01; 7(8):2545-54. PubMed ID: 11489838
    [Abstract] [Full Text] [Related]

  • 39. Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma.
    Vishwamitra D, Shi P, Wilson D, Manshouri R, Vega F, Schlette EJ, Amin HM.
    Haematologica; 2011 Jun 01; 96(6):871-80. PubMed ID: 21330319
    [Abstract] [Full Text] [Related]

  • 40. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 01; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.